Detecting Equine Antipsychotic Drug Abuse
Researchers from The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong, China, have developed a comprehensive screening method for the detection of antipsychotics in horses, using LC–MS/MS.
kapona/Adobe Stock
Researchers from The Hong Kong Jockey Club, Sha Tin Racecourse, Hong Kong, China, have developed a comprehensive screening method for the detection of antipsychotics in horses, using liquid chromatography tandem mass spectrometry (LC–MS/MS) (1).
Antipsychotics are typically used to treat psychotic symptoms in disorders such as schizophrenia or bipolar. However, antipsychotics are also classified as neuroleptics or major tranquilizers, which reduce agitation and result in a calming effect. This gives them a high potential for abuse in equine sports where calming the animal athletes can result in improved performance. For example, prothipendyl, an azaphenothiazine neuroleptic, was suspected to have been administered illegally at low doses to race-horses to improve their performance (2), and in a high profile case from 2004 the antipsychotic drugs fluphenazine and zuclopenthixol were found in the urine and blood samples collected from Waterford Crystal, the horse ridden by Olympic showjumping gold medalist Cian O’Connor in 2004 (3). Therefore, antipsychotics have a long history of abuse in equine sports and effective screening is critical to maintain parity in competitive sports.
Antipsychotic drug usage in humans has risen in recent decades with numerous detection methodologies filling the analytical need to monitor these drugs, however, there are limited publications on the detection of these drugs in equine biological samples, with most being single target methods. Researchers consequently aimed to develop a new method that could simultaneously detect 58 antipsychotics, 19 antidepressants, along with two antihypertensives, an anaesthetic, and a decongestant in equine plasma at sub-parts-per-billion (ppb) to low-ppb levels after solid-phase extraction (SPE).
The resulting method showed sufficient sensitivity and robustness for regular qualitative screening. The method is capable of simultaneously detecting 81 antipsychotics, antidepressants, and other prohibited substances in horse plasma. The applicability of the method was demonstrated by analysing two equine plasma samples reported to contain the drugs reserpine and lidocaine. In combination with the authors’ previous publication using SPE and high resolution accurate mass screening (HRAMS) to detect over 320 other drug targets in equine plasma (4), these two methods are capable of screening over 400 drug targets from one SPE procedure.
References
- A.S.Y. Wong et al., J. Chroma. B.1147, 122132 (2020).
- H. Hagedorn, S. Zuck, and R. Schultz, Dtsch Tierarztl Wochenschr.103(4), 125–127 (1996).
- Waterford Crystal B sample tests positive. The Irish Times. 9 Nov 2004, www.irishtimes.com/news/waterford-crystal-b-sample-tests-positive-1.994582.
- E.N. Ho et al., Drug Test. Anal.5(7), 509–528 (2013).
Measuring Procyanidin Concentration in Wines Using UHPLC
January 24th 2025Researchers from the University of Bordeaux (Villenave d'Ornon, France) report the development and validation of a rapid and quantitative analytical method measuring crown procyanidin concentration in red and white wines using ultra-high performance liquid chromatography (UHPLC) coupled with a ultra-high performance liquid chromatography (Q-TOF) mass spectrometer.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Testing Solutions for Metals and PFAS in Water
January 22nd 2025When it comes to water analysis, it can be challenging for labs to keep up with ever-changing testing regulations while also executing time-efficient, accurate, and risk-mitigating workflows. To ensure the safety of our water, there are a host of national and international regulators such as the US Environmental Protection Agency (EPA), World Health Organization (WHO), and the European Union (EU) that demand stringent testing methods for drinking water and wastewater. Those methods often call for fast implementation and lengthy processes, as well as high sensitivity and reliable instrumentation. This paper explains how your ICP-MS, ICP-OES, and LC-MS-MS workflows can be optimized for compliance with the latest requirements for water testing set by regulations like US EPA methods 200.8, 6010, 6020, and 537.1, along with ISO 17294-2. It will discuss the challenges faced by regulatory labs to meet requirements and present field-proven tips and tricks for simplified implementation and maximized uptime.
